您好,欢迎来到仪器设备网! [登录] [免费注册]
仪器设备网
位置:首页 > 产品库 > Brefeldin A
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Brefeldin A
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Brefeldin A图片
CAS NO:20350-15-6
规格:98%
分子量:280.36
包装与价格:
包装价格(元)
5mg电议
25mg电议
100mg电议

产品介绍
ATPase inhibitor
CAS:20350-15-6
分子式:C16H24O4
分子量:280.36
纯度:98%
存储:Store at -20°C

Background:

Brefeldin A (BFA) is an inhibitor of ATPase with IC50 value of 0.2 μM [1]
ATPase is a chemical enzyme which is essential in the ADP/ATP exchange which process provides chemical potential energy. ATP supplies the energy for many physiological activities such as importing metabolites necessary for cell metabolism, exporting toxins, wastes, and solutes that can hinder cellular processes, cell proliferation, ER stress and so forth [2].
Treatment with BFA could attenuate stimulus-dependent hyperalgesia phenomenon via inhibiting vesicular exocytosis which process is important for ATP release [3]. When tested with cell line HEK293 cells (stably express wild-type (wt) CRELD2), BFA treatment nearly abolished the secretion of wtCRELD2 completely via inhibiting the transportation of proteins from the ER to the Golgi apparatus [4]. In MCF-7 cells and Hela cells, treatment with BFA induced p53 expression via inhibiting ATP which enhanced ER stress [5]. When treated with colorectal cancer cell line HCT116 cells, BFA treatment induced cells apoprosis by inhibiting ATP which functioned in the process of cellular vesicle trafficking [1].
BFA also is reported as an inhibitor for GTP/GDP exchange in a dose-dependent way, which is important in vesicular trafficking [6].
参考文献:
[1] P.M. Wierzbicki, M. Kogut, J. Ruczynski, K. Siedlecka-Kroplewska, L. Kaszubowska, A. Rybarczyk, M. Alenowicz, P. Rekowski, Z. Kmiec, Protein and siRNA delivery by transportan and transportan 10 into colorectal cancer cell lines, Folia Histochem Cytobiol, (2014).
[2] M. Westerterp, A.E. Bochem, L. Yvan-Charvet, A.J. Murphy, N. Wang, A.R. Tall, ATP-binding cassette transporters, atherosclerosis, and inflammation, Circulation research, 114 (2014) 157-170.
[3] E.K. Joseph, P.G. Green, J.D. Levine, ATP release mechanisms of endothelial cell-mediated stimulus-dependent hyperalgesia, The journal of pain : official journal of the American Pain Society, 15 (2014) 771-777.
[4] K. Oh-hashi, Y. Kanamori, Y. Hirata, K. Kiuchi, Characterization of V-ATPase inhibitor-induced secretion of cysteine-rich with EGF-like domains 2, Cell biology and toxicology, 30 (2014) 127-136.
[5] W.C. Lin, Y.C. Chuang, Y.S. Chang, M.D. Lai, Y.N. Teng, I.J. Su, C.C. Wang, K.H. Lee, J.H. Hung, Endoplasmic reticulum stress stimulates p53 expression through NF-kappaB activation, PLoS One, 7 (2012) e39120.
[6] D. Prieto, P. Corchete, Transport of flavonolignans to the culture medium of elicited cell suspensions of Silybum marianum, Journal of plant physiology, 171 (2014) 63-68.